Published On : 09 june 2025
• The global L-Alanyl-L-Glutamine market was valued at US$ 149.14 million in 2024 and is projected to reach US$ 221.03 million by 2031, growing at a CAGR of 6.05% during the forecast period from 2025 to 2031.
Email: help@intelmarketresearch.com +91 9169164321
• L-Alanyl-L-Glutamine is a synthetic dipeptide created by the combination of L-glutamine and L-alanine amino acids, which is intended to improve glutamine's stability and delivery in both clinical use and commercial development. In contrast to free glutamine, which is unstable in solution and degrades quickly, this dipeptide structure is extremely stable in aqueous conditions, so it is well suited for parenteral nutrition and oral supplements. Clinically, L-Alanyl-L-Glutamine is extensively employed for the support of critically ill patients by enhancing gut integrity, facilitating nitrogen retention, and improving immune response during times of metabolic stress.
Email:
•≥ 99% Purity
•98-99%
•<98%
•Ajinomoto
•Jinan Chenghui-Shuangda Chemical
•Kyowa Hakko Bio
•Evonik
•Wuhan Microsen Technology
•Jiangsu Chengxin Pharmaceutical
•Xi'an Lyphar Biotech
Email: help@intelmarketresearch.com +91 9169164321
